| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Lepore Patrick G serves as a Director at MTNB and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 12 buys and 0 sells. Those positions are worth an estimated $442K at current prices.
Historically, Lepore Patrick G's trades have earned a below-average insider score of 28/100 across 7 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -66.7%.
The biggest single holding is MTNB (~$292K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 400,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | VYNE Vyne Therapeutics Inc. | Director | Buy | 15,000 | $2.92 | $43,800.00 | +41.1% | -34.1% | -79.5% | |
| Nov 15, 2023 | VYNE Vyne Therapeutics Inc. | Director | Buy | 13,000 | $3.91 | $50,778.00 | +55.4% | -51.2% | -31.1% | |
| Mar 20, 2023 | VYNE Vyne Therapeutics Inc. | Director | Buy | 20,000 | $2.48 | $49,680.00 | +576.0% | +96.5% | -18.0% | |
| Nov 30, 2021 | VYNE Vyne Therapeutics Inc. | Director | Buy | 12,500 | $1.02 | $12,698.75 | +25.0% | -47.4% | -77.4% | |
| Aug 25, 2021 | VYNE Vyne Therapeutics Inc. | Director | Buy | 12,500 | $1.60 | $20,000.00 | +33.3% | -36.7% | -79.3% | |
| May 26, 2021 | VYNE Vyne Therapeutics Inc. | Director | Buy | 12,500 | $3.60 | $44,957.50 | +50.0% | -56.2% | -89.4% | |
| Mar 15, 2021 | VYNE Vyne Therapeutics Inc. | Director | Buy | 12,500 | $7.41 | $92,562.50 | +100.0% | -47.9% | -92.3% | |
| Dec 3, 2020 | VYNE Vyne Therapeutics Inc. | Director | Buy | 50,000 | $1.71 | $85,425.00 | New | - | - | |
| May 14, 2020 | MTNB Matinas Biopharma Holdings, Inc. | Director | Buy | 100,000 | $0.73 | $73,050.00 | +33.3% | - | - | |
| Nov 15, 2019 | MTNB Matinas Biopharma Holdings, Inc. | Director | Buy | 100,000 | $1.06 | $105,530.00 | +50.0% | - | - |